Knox Van Dyke

KnoxVanDyke.jpg

Knox Van Dyke

Knox Van Dyke, Ph.D.

Knox Van Dyke, Ph.D., is professor emeritus in molecular pharmacology, biochemistry, and public health, at the West Virginia Medical School in Morgantown, West Virginia.

His research is centered in two main areas: chemotherapy and inflammation. These studies include an examination of antimicrobial, antiviral, antimal, and anticancer drugs. Other research is involved with host defense systems and the drugs that affect them.

Articles by Knox Van Dyke

Prevention and Treatment of Chronic Inflammatory Diseases

Sustained release dihydroberberine (DHB) is a dietary supplement that has therapeutic value for the prevention and treatment of a wide range of diseases associated with chronic inflammation, including pre-diabetes and diabetes, heart diseases, viral infections, chronic neuroinflammatory diseases, lung diseases, kidney diseases, liver diseases, and as adjunctive treatment in a variety of cancers. This article describes the rationale for such use, relevant research, add-on therapies, and suggested treatment protocols.